Hong Wang1, Aileen X Wang, Kevin Aylor, Eugene J Barrett. 1. Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Virginia Health System, 450 Ray C. Hunt Drive, Box 801410, Charlottesville, VA, 22908, USA, Hw8t@virginia.edu.
Abstract
AIMS/HYPOTHESIS: As insulin entry into muscle interstitium is rate-limiting for its overall peripheral action, defining the route and regulation of its entry is critical. Caveolin-1 is required for caveola formation in vascular endothelial cells (ECs) and for EC insulin uptake. Whether this requirement reflects simply the need for caveola availability or involves a more active role for caveolae/caveolin-1 is not known. Here, we examined the role of insulin-stimulated tyrosine 14 (Tyr(14))-caveolin-1 phosphorylation in mediating EC insulin uptake and the role of cellular Src-kinase (cSrc), TNF-α/IL-6 and high fat diet (HFD) in regulating this process. METHODS: Freshly isolated ECs from normal or HFD-fed rats and/or cultured ECs were treated with FITC-labelled or regular insulin with or without a Src or phosphotidylinositol-3-kinase inhibitor, TNF-α or IL-6, or transfecting FLAG-tagged wild-type (WT) or mutant (Y14F) caveolin-1. Tyr(14)-caveolin-1/Tyr(416) cSrc phosphorylation and FITC-insulin uptake were quantified by immunostaining and/or western blots. RESULTS: Insulin stimulated Tyr(14)-caveolin-1 phosphorylation during EC insulin uptake. Inhibiting cSrc, but not phosphotidylinositol-3-kinase, reduced insulin-stimulated caveolin-1 phosphorylation. Furthermore, inhibiting cSrc reduced FITC-insulin uptake by ∼50%. Overexpression of caveolin-1Y14F inhibited, while overexpression of WT caveolin-1 increased, FITC-insulin uptake. Exposure of ECs to TNF-α or IL-6, or to 1-week HFD feeding eliminated insulin-stimulated caveolin-1 phosphorylation and inhibited FITC-insulin uptake to a similar extent. CONCLUSIONS/ INTERPRETATION: Insulin stimulation of its own uptake requires caveolin-1 phosphorylation and Src-kinase activity. HFD in vivo and proinflammatory cytokines in vitro both inhibit this process.
AIMS/HYPOTHESIS: As insulin entry into muscle interstitium is rate-limiting for its overall peripheral action, defining the route and regulation of its entry is critical. Caveolin-1 is required for caveola formation in vascular endothelial cells (ECs) and for EC insulin uptake. Whether this requirement reflects simply the need for caveola availability or involves a more active role for caveolae/caveolin-1 is not known. Here, we examined the role of insulin-stimulated tyrosine 14 (Tyr(14))-caveolin-1 phosphorylation in mediating EC insulin uptake and the role of cellular Src-kinase (cSrc), TNF-α/IL-6 and high fat diet (HFD) in regulating this process. METHODS: Freshly isolated ECs from normal or HFD-fed rats and/or cultured ECs were treated with FITC-labelled or regular insulin with or without a Src or phosphotidylinositol-3-kinase inhibitor, TNF-α or IL-6, or transfecting FLAG-tagged wild-type (WT) or mutant (Y14F) caveolin-1. Tyr(14)-caveolin-1/Tyr(416) cSrc phosphorylation and FITC-insulin uptake were quantified by immunostaining and/or western blots. RESULTS:Insulin stimulated Tyr(14)-caveolin-1 phosphorylation during EC insulin uptake. Inhibiting cSrc, but not phosphotidylinositol-3-kinase, reduced insulin-stimulated caveolin-1 phosphorylation. Furthermore, inhibiting cSrc reduced FITC-insulin uptake by ∼50%. Overexpression of caveolin-1Y14F inhibited, while overexpression of WT caveolin-1 increased, FITC-insulin uptake. Exposure of ECs to TNF-α or IL-6, or to 1-week HFD feeding eliminated insulin-stimulated caveolin-1 phosphorylation and inhibited FITC-insulin uptake to a similar extent. CONCLUSIONS/ INTERPRETATION:Insulin stimulation of its own uptake requires caveolin-1 phosphorylation and Src-kinase activity. HFD in vivo and proinflammatory cytokines in vitro both inhibit this process.
Authors: Lei Zhang; Catherine M Wheatley; Stephen M Richards; Eugene J Barrett; Michael G Clark; Stephen Rattigan Journal: Am J Physiol Endocrinol Metab Date: 2003-05-20 Impact factor: 4.310
Authors: David Vicent; Jacob Ilany; Tatsuya Kondo; Keiko Naruse; Simon J Fisher; Yaz Y Kisanuki; Sven Bursell; Masashi Yanagisawa; George L King; C Ronald Kahn Journal: J Clin Invest Date: 2003-05 Impact factor: 14.808
Authors: Zhenlong Chen; Farnaz R Bakhshi; Ayesha N Shajahan; Tiffany Sharma; Mao Mao; Andy Trane; Pascal Bernatchez; Geerten P van Nieuw Amerongen; Marcelo G Bonini; Randal A Skidgel; Asrar B Malik; Richard D Minshall Journal: Mol Biol Cell Date: 2012-02-09 Impact factor: 4.138
Authors: Ian M Williams; P Mason McClatchey; Deanna P Bracy; Jeffrey S Bonner; Francisco A Valenzuela; David H Wasserman Journal: Obesity (Silver Spring) Date: 2020-01-05 Impact factor: 5.002
Authors: Adriana M Zimnicka; Yawer S Husain; Ayesha N Shajahan; Maria Sverdlov; Oleg Chaga; Zhenlong Chen; Peter T Toth; Jennifer Klomp; Andrei V Karginov; Chinnaswamy Tiruppathi; Asrar B Malik; Richard D Minshall Journal: Mol Biol Cell Date: 2016-05-11 Impact factor: 4.138
Authors: Zhenlong Chen; Suellen D S Oliveira; Adriana M Zimnicka; Ying Jiang; Tiffany Sharma; Stone Chen; Orly Lazarov; Marcelo G Bonini; Jacob M Haus; Richard D Minshall Journal: Mol Biol Cell Date: 2018-03-22 Impact factor: 4.138